2A Pharma ApS: Financial statements 2025
CVR: 39391597
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
2A Pharma ApS (CVR 39391597) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 587,253 and a net result of DKK -712,675 compared with DKK 4,297 the year before. That is a decrease of 0.7% compared with the year before. Equity in the 2025 report amounted to DKK 263,490. The solvency ratio was 85.3%.
- Gross Profit
- DKK 587,253
- Profit/Loss
- DKK -712,675
- Equity
- DKK 263,490
- Total Assets
- DKK 309,075
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 587 t. | -713 t. | 263 t. | 0 |
| 2024 | - | 591 t. | 4 t. | 976 t. | 2 |
| 2023 | - | 159 t. | -43 t. | 672 t. | 2 |
| 2022 | - | -210 t. | -1.5 mio. | -586 t. | 2 |
| 2021 | - | 1.9 mio. | 272 t. | 938 t. | 2 |
How creditworthy is 2A Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
2A Pharma ApS has published its annual report for 2024. Gross profit came to DKK 591,317, and the net result was DKK 4,297.
About 2A Pharma ApS
2A Pharma ApS is a Danish company of the type Anpartsselskab based in Aalborg Øst, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Preben Bruun-Nyzell and Josephus Dirk Vestergaard Nieland. The company is owned by 2A Pharma AB. The company has 2 employees (2018). In 2025, the company reported a gross profit of DKK 587,253 and a net result of DKK -712,675 compared with DKK 4,297 the year before. Equity in the 2025 report amounted to DKK 263,490.